2013 AMSN Convention

311 - Intensive Insulin Therapies During Hospitalization and Beyond

Sep 29, 2013 10:00am ‐ Sep 29, 2013 11:00am

Standard: $20.00
Members: $0.00

Description

Evidence indicates that glycemic control of the hospitalized patient with hyperglycemia improves health outcomes both in and out of the hospital. This session focuses on the role of intensive insulin therapy in managing the hospitalized patient and provide the medical-surgical nurse with information to successfully transition the patient for discharge.

Contact hours available until 9/29/2015.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Conflict of Interest Disclosure:
Angela Thompson discloses that she is on the advisory board for Novo-Nordisk.

Planning Committee members have no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

This educational activity has been co-provided by Anthony J. Jannetti, Inc. and Academy of Medical-Surgical Nurses.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC-COA)

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered nursing, Provider Number, CEP 5387.

Objectives:

  • Describe the relationship between glycemic control and health outcomes in the hospitalized patient with or without diabetes.
  • Discuss the current practice guidelines for glycemic control in the hospital setting.
  • Identify effective strategies for obtaining glucose control in the hospitalized patient and the role of intensive insulin therapy.
  • Discuss how to create an effective discharge teaching plan for insulin therapy.

Speaker(s):

You must be logged in and own this session in order to post comments.